Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-28

FDA Approved: LACOSAMIDE — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for lacosamide submitted by Fresenius Kabi USA, LLC, updating the product's approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

SUPPL AP for LACOSAMIDE (LACOSAMIDE)